The results of our study showed weak-moderate MMP-2, MMP-9 and strong TIMP-2, TIMP-1 immunohistochemical expression of MTC, although no differences by MTC type were observed. This evidence concerns the gene MMP2 and medullary thyroid gland carcinoma.